BOT 2.67% 36.5¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-15

  1. 24 Posts.
    lightbulb Created with Sketch. 3
    > No clinical efficacy, safety, pharmacology, non-clinical or manufacturing issues were raised and noadditional clinical studies are required by FDA to support NDA approval

    Pretty happy with that all things considered.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
-0.010(2.67%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.0¢ 36.5¢ $736.5K 1.980M

Buyers (Bids)

No. Vol. Price($)
18 557533 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 291573 13
View Market Depth
Last trade - 11.58am 30/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.